FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/11/076173 [Registered on: 04/11/2024] Trial Registered Prospectively
Last Modified On: 01/11/2024
Post Graduate Thesis  No 
Type of Trial  Observational 
Type of Study   Cohort Study 
Study Design  Other 
Public Title of Study   Using blood investigation to predict mechanical ventilation prediction in Neuromuscular disease(Gullian Barre syndrome) patients admitted in ICU 
Scientific Title of Study   Predictive role of Immune-Nutritional Indices and Muscle atrophy in determining ventilator management outcomes in Guillain-Barre Syndrome (GBS) Patients in the intensive care unit 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Shweta S Naik 
Designation  Associate Professor 
Affiliation  National Institute of Mental Health and Neurosciences 
Address  Faculty Building Third Floor Department of Neuroanaesthesia and Neurocritical care National Institute of Mental Health and Neurosciences Hosur Main Road Bangalore

Bangalore
KARNATAKA
560028
India 
Phone  9480829837  
Fax    
Email  neurodocms@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Shweta S Naik 
Designation  Associate Professor 
Affiliation  National Institute of Mental Health and Neurosciences 
Address  Faculty Building Third Floor Department of Neuroanaesthesia and Neurocritical care National Institute of Mental Health and Neurosciences Hosur Main Road Bangalore


KARNATAKA
560028
India 
Phone  9480829837  
Fax    
Email  neurodocms@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Shweta S Naik 
Designation  Associate Professor 
Affiliation  National Institute of Mental Health and Neurosciences 
Address  Faculty Building Third Floor Department of Neuroanaesthesia and Neurocritical care National Institute of Mental Health and Neurosciences Hosur Main Road Bangalore


KARNATAKA
560028
India 
Phone  9480829837  
Fax    
Email  neurodocms@gmail.com  
 
Source of Monetary or Material Support  
Department of Neuroanaesthesia and Neurocritical Care National Institute of Mental Health and Neurosciences Hosur Main road Bengaluru Karnataka-560028 
 
Primary Sponsor  
Name  Dr Shweta S Naik 
Address  Faculty Building Third Floor Department of Neuroanaesthesia and Neurocritical Care National Institute of Mental Health and Neurosciences Hosur Main road Bengaluru Karnataka-560028 
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Shweta S Naik  National Institute of Mental Health and Neurosciences  Department of Neuroanaesthesia and Neurocritical Care National Institute of Mental Health and Neurosciences Hosur Main road Bengaluru Karnataka-560028
Bangalore
KARNATAKA 
9480829837

neurodocms@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
National Institute of Mental Health and Neuroscience  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: G610||Guillain-Barre syndrome,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  NIL  NIL 
Comparator Agent  NIL  NIL 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  75.00 Year(s)
Gender  Both 
Details  1. 18 – 75 years
2. GBS patients admitted to ICU
 
 
ExclusionCriteria 
Details  1. Patients with trauma to lower limbs
2. Unable to get an ultrasound image
3. Refusal to give consent
4. Pregnancy
 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
1. To evaluate the predictive value of baseline immune-nutritional indices for muscle mass change in Guillain-Barre Syndrome (GBS) patients requiring mechanical ventilation.  blood investigation done at baseline will be taken. muscle ultrasound at day 0, day 3 and discharge will be done 
 
Secondary Outcome  
Outcome  TimePoints 
2. To determine the influence of immune-nutritional indices on ventilator management outcomes (tracheostomy, extubation, or non-intubation) in Guillain-Barre Syndrome patients  blood investigation done at baseline will be taken. muscle ultrasound at day 0, day 3, day 7 and discharge will be done 
 
Target Sample Size   Total Sample Size="50"
Sample Size from India="50" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   13/11/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="3"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

This study aims to explore if immune-nutritional indices which are values derived from routine blood investigations like complete blood count, liver function tests and lipid profile and muscle loss can predict airway management outcomes in Guillain-Barré Syndrome (GBS) patients in the ICU. GBS is an autoimmune disorder that can progress quickly, causing muscle weakness and sometimes leading to breathing difficulties, which may require intensive respiratory support. Identifying early predictors for ventilator needs could improve care and resource management for these patients.

The study will focus on assessing immune-nutritional indices, such as the Prognostic Nutritional Index (PNI) and Neutrophil-to-Lymphocyte Ratio (NLR), at ICU admission. These markers, which reflect inflammation and nutritional health, may help predict outcomes like tracheostomy, extubation, or avoiding intubation. Additionally, muscle atrophy, measured through ultrasound scans of the thigh muscle (rectus femoris), will be monitored to assess its impact on the length of ICU stay, days on ventilation, and hospital stay

 
Close